Bevacizumab in the treatment of uterine cervix carcinoma

Simple item page
dc.contributor.authorDvořák Josefcs
dc.date.accessioned2021-01-14T18:07:24Z
dc.date.available21-36-2020en
dc.date.available2021-01-14T18:07:24Z
dc.date.issued2020cs
dc.date.updated21-38-2020en
dc.format.extent3cs
dc.identifier.issn2464-7195cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/158701
dc.language.isoczecs
dc.relation.ispartofOnkologická Revueen
dc.relation.ispartofseries0cs
dc.subjectuterine cervix carcinomacs
dc.subjectsystemic treatmentcs
dc.subjectchemotherapycs
dc.subjectbevacizumabcs
dc.titleBevacizumab in the treatment of uterine cervix carcinomaen
dc.titleBevacizumab v léčbě pacientek s karcinomem děložního hrdlacs
local.citation.epage51-53cs
local.citation.spage51-53cs
local.identifier.publikace8028
Files
Collections